Pubdate: Tue, 14 Jan 2003 Source: Canadian Press (Canada Wire) Copyright: 2003 The Canadian Press (CP) Author: Dean Beeby OTTAWA'S MARIJUANA MAVEN PUTS BRAKES ON DISTRIBUTION PROPOSAL: DOCUMENTS (CP) - The chief of Ottawa's medical marijuana program has been putting the brakes on a Health Canada proposal that would give needy patients direct access to government dope. A newly released document shows that Cindy Cripps-Prawak has been fighting a proposed policy shift that would deliver government-certified marijuana to chronically ill Canadians. Currently, Health Canada will provide its standardized marijuana only to accredited researchers, who would then dispense it to select patients in clinical trials. Patients not enrolled in such trials can seek federal authorization to possess marijuana to alleviate symptoms - but they have to get the stuff on their own from the street. They can also grow it from seeds or have someone else do it for them. Street dope, which can vary wildly in quality, is not legal though authorized patients can legally smoke it. A document released under the Access to Information Act shows that Health Canada policymakers are looking to end that conundrum through a major policy shift that would provide government marijuana directly to approved patients. The draft policy, entitled Medical Marijuana - Supply and Distribution and dated May 31 last year, would "provide access to (research grade) marijuana for medical purposes for patients unable to enroll in clinical trials," says the document. "It will not be possible for all patients to enroll in a controlled or open label clinical trial. In these instances, it will be necessary to consider providing patients with access to the federal supply of dried marijuana for medical purposes. . . ." Such a shift, which would be an about-face for Health Minister Anne McLellan, could help resolve a recent series of court decisions that have called into question the validity of Canada's marijuana laws. But the move is being opposed by the very civil servant who would be in charge of implementing it. In marginal notes to the draft policy statement, Cripps-Prawak says the shift would create a bad precedent by undermining Canada's drug-approval process, which requires clinical proof before drugs can be made available to the public. "This option does not support Health Canada responsibility with respect to the safety and well-being of Canadians," she wrote on June 5. Cripps-Prawak also warns that Health Canada would be in a conflict of interest since it would be both regulator and distributor of a drug, calling the proposal a "non-credible approach." "The recommendation should be to not deviate from the current policy of directing the product to research purposes only," she wrote. In an interview, Cripps-Prawak said "the document is still a draft and work continues." But she added that her concerns about direct distribution remain. "Where on first blush something might be a very good idea, looking at the ramifications and implications, sometimes you have to sit back a little bit and give it a little more thought," she said from Ottawa. Cripps-Prawak, director of the Office of Cannabis Medical Access since April 2001, also dismissed suggestions the department had previously indicated it would provide dope outside clinical trials. "From my perspective, we never shifted gears. . . . Maybe it was a problem with language." Health Canada is paying Prairie Plant Systems of Saskatoon $5.7 million over five years to grow high-grade marijuana in an abandoned mine section in Flin Flon, Man. The first crop of 74 kilograms, delivered in December 2001, contained 185 different varieties because the company was forced to rely on seeds from police seizures across the country. The original plan to obtain standardized seeds from the National Institute on Drug Abuse in Bethesda, Md., fell through. Last month, Prairie Plant Systems delivered a second crop of 200 kilograms based on the two best strains from the first crop. The crop's level of THC, the main active ingredient in marijuana, is higher than 10 per cent though tests are still being conducted. This second standardized and certified crop will be used to supply clinical trials with a reliable product. - - Some facts and figures about government-certified marijuana being grown in Flin Flon, Man.: Purpose - Health Canada wants standardized supply of marijuana for accredited researchers to determine whether the substance has health benefits. Contract - In December 2000, Prairie Plant Systems of Saskatoon awarded a five-year, $5.75-million contract to grow marijuana for Health Canada in an abandoned mine section in Flin Flon, Man. Source - Prairie Plant Systems originally to obtain quality seeds from the National Institute on Drug Abuse in Bethesda, Md. Delays forced them instead to use more than 10,000 seeds seized by various police forces across the country. Only a third produced plants. First crop - First crop of 74 kilograms delivered December 2001 had 185 varieties, with broad range of quality. Two best strains - officially known as MS-17/338 and MS-9/934 - later picked for their hardiness and potency. A third strong strain held in reserve. Second crop - Second crop of 200 kilograms delivered in December 2002, based on planted cuttings from the two best strains to ensure genetic consistency. Tests - Early results suggest a 10 per cent or higher level of THC, the most active ingredient of marijuana, in the second crop. Also being tested for microbes and for zinc-copper content. May be months before distribution to researchers. Processing and storage - Dried crop stored at Flin Flon to be bagged and labelled as necessary. No plans at present to produce rolled marijuana cigarettes. Current trials - The Community Research Initiative of Toronto is testing the effect of marijuana on the appetites of AIDS patients. A group at McGill University in Montreal is testing the effects of smoked marijuana on neuropathic pain. Health Canada provides funding but not the marijuana, which currently comes from the National Institute on Drug Abuse. - --- MAP posted-by: Josh